AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1493086
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg glucagon from pancreatic extraction intramuscularly
Trial: 1493086
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg genetically engineered glucagon intramuscularly
Trial: 1493086
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g glucose intravenously
Trial: 2859712
Drug: Astemizole, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole, 10 mg on rising
Trial: 2859712
Drug: Terfenadine, 60
RxNorm normalized name: Terfenadine, 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine, 60 mg on rising and in the evening
Trial: 26710337
Drug: Pharmacogenetic warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacogenetic warfarin dosing
Trial: 22056474
Drug: Lipid-lowering medication
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-lowering medication
Trial: 18813411
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate 50 mg daily for 60 days
Trial: 14690101
Drug: Epidural levobupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural levobupivacaine 0.5% 15 mL
Trial: 14690101
Drug: Epidural ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ropivacaine 0.75% 15 mL
Trial: 10733052
Drug: Metrifonate (60/80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate (60/80 mg)
Trial: 10733052
Drug: Metrifonate (40/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate (40/50 mg)
Trial: 8604962
Drug: Active antihypertensive
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active antihypertensive drug therapy
Trial: 29280723
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy with adjustment of challenge-skill balance
Trial: 29280723
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy without adjustment of challenge-skill balance
Trial: 15856076
Drug: metoclopramide (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide (up to 40 mg/day)
Trial: 15856076
Drug: naproxen (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen (up to 1000 mg/day)
Trial: 14716965
Drug: Fluticasone/salmeterol combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone/salmeterol combination 250/50 micrograms one inhalation twice daily
Trial: 14716965
Drug: CFC beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CFC beclomethasone dipropionate 250 micrograms two puffs twice daily plus montelukast 10 mg in the evening
Trial: 15537846
Drug: Non-selective beta-blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-selective beta-blockers
Trial: 15537846
Drug: Novel therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel therapies targeting intrahepatic resistance
Trial: 9046455
Drug: Stretching exercises
RxNorm normalized name: Mederma Stretch Mark Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stretching exercises (two unsupervised sessions daily over the same time period)
Trial: 905580
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg PGE2 vaginal suppositories
Trial: 905580
Drug: Oxytocin induction
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin induction (with or without estrogen pre‐treatment)
Trial: 31881392
Drug: Cenicriviroc (CVC)
RxNorm normalized name: salicylic acid
DrugBank: Cenicriviroc (DB11758)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cenicriviroc (CVC) 150 mg orally once daily
Trial: 30844878
Drug: BUP-XR 300/300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUP-XR 300/300 mg
Trial: 30844878
Drug: BUP-XR 300/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUP-XR 300/100 mg
Trial: 21308781
Drug: Risperidone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (20 patients, 3 mg daily)
Trial: 21308781
Drug: Aripiprazole (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (21 patients, 15 mg daily)
Trial: 19363695
Drug: Carbohydrate beverage
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate beverage (200 ml containing 12.5% maltodextrin) given 2 hours before operation
Trial: 16222548
Drug: Levamisole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (2.5 mg/kg on alternate days for 1 year)
Trial: 16222548
Drug: Control (low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (low-dose prednisolone <0.5 mg/kg on alternate days for 1 year)
Trial: 12734506
Drug: Tazarotene cream
RxNorm normalized name: Tazarotene Cream
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tazarotene cream 0.05%
Trial: 9301382
Drug: Captopril 0.8‐0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 0.8‐0.9 mg kg‐1 orally, 45 min before induction of anaesthesia
Trial: 9301382
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no preoperative medication)
Trial: 8130356
Drug: Steroid-free immunosuppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free immunosuppression (complete avoidance of steroids or withdrawal of steroids less than 3 months after transplantation)
Trial: 8130356
Drug: Steroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid therapy (control group)
Trial: 3481333
Drug: Ofloxacin 200mg
RxNorm normalized name: OFLOXACIN 200MG TAB
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin 200mg once daily
Trial: 3481333
Drug: Norfloxacin 400mg
RxNorm normalized name: NORFLOXACIN 400MG TAB
DrugBank: Norfloxacin (DB01059)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Norfloxacin 400mg twice daily
Trial: 31935146
Drug: 308-nm excimer
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 308-nm excimer laser (three times weekly for 8 weeks)
Trial: 31520258
Drug: Auricular acupuncture
RxNorm normalized name: fluocinolone
DrugBank: Fluocinolone (DB12553)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular acupuncture therapy
Trial: 25876341
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of flunarizine hydrochloride capsules (5mg, once every night for 14 days)
Trial: 25876341
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of flunarizine hydrochloride capsules
Trial: 25876341
Drug: Auricular acupuncture
RxNorm normalized name: fluocinolone
DrugBank: Fluocinolone (DB12553)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular acupuncture therapy and medicine group
Trial: 21563952
Drug: Induction phase
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction phase (no oral hygiene for 21 days)
Trial: 20463812
Drug: Azithromycin (a
RxNorm normalized name: azithromycin (as azithromycin dihydrate) 500 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (a macrolide antibiotic)
Trial: 18677972
Drug: Suplatast tosilate
RxNorm normalized name: Edoxaban Tosylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suplatast tosilate (300 mg/day)
Trial: 2005233
Drug: 2% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% chlorhexidine gel
Trial: 2005233
Drug: 4% stannous
RxNorm normalized name: Stanimax 0.4% Stannous Fluoride Dental Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% stannous fluoride gel
Trial: 2005233
Drug: Amine fluoride
RxNorm normalized name: triethylene amine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amine fluoride gel (1.25% fluoride)
Trial: 326281
Drug: Diazepam 0.2
RxNorm normalized name: diazepam 0.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.2 mg/kg
Trial: 7046500
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid 100 mg
Trial: 31382932
Drug: Online Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online Cognitive Behavioral Therapy (CBT)
Trial: 29191450
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of 1.1 mL (275 mg) of hydroxyprogesterone caproate (HPC) administered using an autoinjector
Trial: 29191450
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 1 mL (250 mg) of hydroxyprogesterone caproate (HPC)
Trial: 24210570
Drug: tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tamsulosin 0.4 mg
Trial: 24210570
Drug: alfuzosin 10
RxNorm normalized name: Alfuzosin 10mg Oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alfuzosin 10 mg
Trial: 15500103
Drug: Acetated Ringer's
RxNorm normalized name: ACETATED RINGER'S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetated Ringer's solution (1,000 ml, n=8)
Trial: 15500103
Drug: 6% hydroxyethylstarch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% hydroxyethylstarch (1,000 ml, n=9)
Trial: 11474722
Drug: Mood-freezing pill
RxNorm normalized name: Freez Eez
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mood-freezing pill
Trial: 9558806
Drug: Eclectic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eclectic treatment programs
Trial: 9558806
Drug: Comprehensive clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive clinical treatment including hypnosis
Trial: 3308390
Drug: Minaprine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minaprine (100 mg b.i.d.)
Trial: 3308390
Drug: Imipramine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (50 mg b.i.d.)
Trial: 21812904
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg
Trial: 25004024
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) in patients with pulmonary embolism
Trial: 25004024
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) in patients without pulmonary embolism
Trial: 11263272
Drug: Garlicin injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlicin injection (60 mg/day for 10 days)
Trial: 8644686
Drug: Crackers with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crackers with cream cheese
Trial: 8644686
Drug: Crackers with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crackers with nonfat cream cheese
Trial: 6337669
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (medical measures, modified splenectomy, oesophagogastric devascularization)
Trial: 20371056
Drug: Conventional Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Care (CC)
Trial: 30566441
Drug: Supported Self-help
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supported Self-help Preventive Cognitive Therapy (S-PCT)
Trial: 21515562
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (sequential and standard treatment)
Trial: 14644054
Drug: Cognitive-behavioral and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral and family treatment components
Trial: 14644054
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment approach
Trial: 8884873
Drug: 4 IU/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 IU/ml in a bicarbonate buffer dissolved in 0.9% benzyl alcohol (approximately 1.37 mg/ml)
Trial: 8884873
Drug: 5.9 IU/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.9 IU/ml in a phosphate buffer dissolved in 1.5% benzyl alcohol (approximately 2 mg/ml)
Trial: 8884873
Drug: 11.7 IU/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11.7 IU/ml in a phosphate buffer dissolved in 1.5% benzyl alcohol (approximately 4 mg/ml)
Trial: 8884873
Drug: 5.9 IU/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.9 IU/ml
Trial: 8884873
Drug: 11.7 IU/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11.7 IU/ml
Trial: 8884873
Drug: 4 IU/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 IU/ml
Trial: 1676318
Drug: Cabergoline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (1 mg, two 0.5 mg tablets and one placebo tablet within 27 hours after delivery, then placebo twice daily for 14 days)
Trial: 1676318
Drug: Bromocriptine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (2.5 mg, two placebo tablets within 27 hours after delivery, then 2.5 mg twice daily for 14 days)
Trial: 18469148
Drug: Losartan (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (2 microg/l)
Trial: 17993594
Drug: Nitro-L-arginine (NLA,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitro-L-arginine (NLA, 10 mM)
Trial: 12601840
Drug: Both hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both hormone markers unaltered
Trial: 8750077
Drug: Preference assessment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preference assessment and simple, low‐effort treatment procedure
Trial: 31776122
Drug: Short term
RxNorm normalized name: Short Term Oral Swab System KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short term exposure to PM2.5 (1 µg/m3 increase)
Trial: 29396118
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (feedback of screening results only)
Trial: 27120082
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg single dose on the evening prior to surgery; 40 mg on the morning of surgery; three further doses of 40 mg on the evenings of postoperative days 0, 1, and 2)
Trial: 23681396
Drug: Atorvastatin and
RxNorm normalized name: atorvastatin and ezetimibe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin and Placebo
Trial: 22356933
Drug: Symbiotic shake
RxNorm normalized name: North American coral snake antivenin
DrugBank: Coral snake (micrurus fulvius) immune globulin antivenin (equine) (DB13883)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symbiotic shake containing Lactobacillus acidophilus, Bifidobacterium bifidum, and fructooligosaccharides, 200 mL daily for 30 days.
Trial: 22356933
Drug: Placebo shake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo shake without symbiotic bacteria, 200 mL daily for 30 days.
Trial: 20606661
Drug: Certolizumab (biologic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Certolizumab (biologic therapy)
Trial: 17256746
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (ADV) monotherapy (n = 14)
Trial: 16398422
Drug: Integrated traditional
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated traditional and Western medicine (ITWM)
Trial: 23275012
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (WM)
Trial: 9526923
Drug: Quality assurance
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quality assurance guidelines developed by the U.S. Food and Drug Administration and various dental specialties.
Trial: 9526923
Drug: Clinical outcomes
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical outcomes of treatment and health and well-being measures.
Trial: 9526923
Drug: Managed care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Managed care implications for quality of periodontal treatment and patient management.
Trial: 19956980
Drug: Voriconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voriconazole (400 mg i.v. every 12 h for two doses, followed by 300 mg BID)
Trial: 19956980
Drug: Itraconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (200 mg i.v. twice daily for 2 days, followed by 200 mg i.v. daily)
Trial: 19375108
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg pentosan polysulfate sodium per day
Trial: 17343008
Drug: Yiqi Huoxue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yiqi Huoxue Recipe (YHR) combined with polyene phosphatidycholine capsule (PPC)
Trial: 17343008
Drug: Polyene phosphatidycholine
RxNorm normalized name: phosphatidylcholine, soybean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyene phosphatidycholine capsule (PPC) alone
Trial: 16297506
Drug: Standard diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard diet plus two high-protein/energy supplements containing additional arginine (9 g), vitamin C (500 mg) and zinc (30 mg)
Trial: 16297506
Drug: Standard diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard diet plus two high-protein/energy supplements
Trial: 9842809
Drug: Succinylcholine (Sch)
DrugBank: Succinylcholine (DB00202)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine (Sch) 1.5 mg/kg
Trial: 9842809
Drug: Rocuronium (Roc)
DrugBank: Rocuronium (DB00728)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rocuronium (Roc) 1.2 mg/kg
Trial: 23864647
Drug: Phenytoin (184
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (184 mg once daily for 7 days post-delivery)
Trial: 23864647
Drug: Control (zidovudine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (zidovudine pre-delivery, single-dose nevirapine/zidovudine/lamivudine at delivery and zidovudine/lamivudine for 7 days post-delivery)
Trial: 21350434
Drug: Oral methylphenidate
RxNorm normalized name: methylphenidate Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral methylphenidate (MPH)
Trial: 16809647
Drug: Water-soluble lubricant
RxNorm normalized name: WATER SOLUBLE BASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water-soluble lubricant gel
Trial: 16809647
Drug: No gel
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No gel (standard of care)
Trial: 12518293
Drug: Ketamine (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (bolus 0.23 mg/kg; 0.5 mg/kg over 45 min to a maximum 1 hr)
Trial: 12020396
Drug: 5'‐DFUR administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5'‐DFUR administered orally for 6 months
Trial: 16714187
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus dipyridamole
Trial: 29882727
Drug: e-prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: e-prescription
Trial: 26044464
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement (150 kcal, 20 g whey protein, 800 IU vitamin D)
Trial: 19565475
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg CP-690,550 twice daily
Trial: 19565475
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg CP-690,550 twice daily
Trial: 19565475
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg CP-690,550 twice daily
Trial: 19565475
Drug: All CP-690,550
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All CP-690,550 treatment arms
Trial: 19565475
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg and 30 mg CP-690,550
Trial: 15302243
Drug: Soft collar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft collar treatment for 3 weeks followed by the same exercise regime
Trial: 9436283
Drug: Non-T1c tumors
RxNorm normalized name: HUMAN BREAST TUMOR CELL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-T1c tumors with PSA < 4 ng/ml
Trial: 27501614
Drug: Intra-Articular Infiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-Articular Infiltration (IA) with 15 mL of 0.25% bupivacaine into the knee joint and 5 mL infiltrated along the incision sites.
Trial: 27501614
Drug: Femoral Nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femoral Nerve Block (FNB) with 20 mL of 0.25% bupivacaine under ultrasound guidance.